"International Multi-center Clinical Trials" conference, initiated by Noppen and co-organized by Shanghai Clinical Research Center (SCRC) will be held on Dec.9th-10th in Shanghai.

 

International Multi-center Clinical Trials are considered a quick method for pharmaceutical companies to get their products into the global market. Currently, over 15,000 global clinical trials are being conducted in the larger Asian Pacific market, which includes a growing number of trials conducted in China. According to the SFDA, there is increasing popularity to use China as a location for clinical trials, and many more pharmaceutical companies are also choosing China as their global clinical trial center.

 

To provide an inside view into global clinical trials in China, the "International Multi-center Clinical Trials" conference, as the 4th Annual Conference in Noppen´s Clinical Trial Series, will act as a platform to help you optimize global clinical processes while ensuring regulatory compliance; provide you with knowledge of changing government regulations and help you build a clinical strategy to successfully introduce your products quickly to the market.

 

Session A: Clinical Trials Go Global - China´s Clinical Trial Environment Analyses

Session B: Global Clinical Trial Preparation, Design, and Clinical Operation

Session C: Innovative Trial Design and Trial Data Management

Session D: Issues in IMCT and Key Points to Note

Session E: Panel Discussion: Partnership Between Pharmaceutical Companies and Hospitals -- Building Mutually Beneficial Relations

Session F: Medical Imaging in Clinical Trials and Surrogate End Point Discussions

Session G: Pharmacoeconomics in Clinical Trials

Session H: Ethical Issues in Global Clinical Trials

Session I: Global Trials Safety Surveillance and Risk Management

Session J: Panel Discussion: Challenges and Advantages of Global Clinical Trials in China

 

For more information, please refer to the website below:
http://www.noppen.com.cn/events/clinical_trials/clinical_trials.asp